• Danaher (NYSE:DHR) has launched a major euro-denominated debt offering of nearly €3b in senior notes.
• The financing is intended to help fund Danaher’s pending acquisition of Masimo Corporation.
• The senior notes have been priced and are expected to close in the near term.

Danaher operates across life sciences, diagnostics and related technologies, and the planned acquisition of Masimo would expand its presence in patient monitoring and medical devices. By turning to euro-denominated senior notes for a large portion of the funding, the company is adding a significant new layer to its capital structure while keeping its focus on health care and medtech exposure.

For investors tracking NYSE:DHR, this funding move raises practical questions about future interest expense, balance sheet flexibility and integration priorities if and when Masimo is acquired. The way Danaher sequences this debt issuance, the potential closing of the deal and any subsequent portfolio decisions may influence how its business mix, cash flows and capital allocation options develop over time.

Stay updated on the most important news stories for Danaher by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Danaher.

Quick Assessment

• ✅ Price vs Analyst Target: At US$184.04 versus a consensus target of about US$251, the price sits roughly 27% below analyst expectations.
• ✅ Simply Wall St Valuation: Shares are described as trading 15.1% below an estimated fair value, with a P/E of 35.4 versus a sector average of 33.8.
• ❌ Recent Momentum: The 30 day return of about a 3.1% decline shows recent weakness despite the Masimo funding news.

There is only one way to know the right time to buy, sell or hold Danaher. Head to Simply Wall St's company report for the latest analysis of Danaher's Fair Value.

Key Considerations

• 📊 Nearly €3b of new euro debt adds funding capacity for the Masimo deal and changes the mix of Danaher's liabilities.
• 📊 Watch future interest expense, leverage ratios and management commentary on integration plans for Masimo once the notes close.
• ⚠️ Higher debt servicing in a different currency could pressure cash flows if acquisition synergies or growth do not offset the added obligations.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Danaher analysis. Alternatively, you can check out the community page for Danaher to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.